Literature DB >> 11819111

Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy.

Helmut Witzigmann1, Clemens Loracher, Felix Geissler, Theodor Wagner, Andrea Tannapfel, Dirk Uhlmann, Karel Caca, Johann Hauss, John Adolf Hehl.   

Abstract

BACKGROUND AND AIMS: Neuroendocrine tumours (NTs) of the duodenum are uncommon neoplasms. They represent a heterogeneous spectrum of subtypes and may be associated with von Recklinghausen's disease type I (VRD) and multiple endocrine neoplasia type I. There are few studies concerning the biological characteristics and adequate therapy of these tumours. PATIENTS AND METHODS: We report on a retrospective analysis of 12 patients with NTs of the duodenum: six non-ampullary (naNTs) and six ampullary tumours (aNTs). These patients were treated between January 1992 and January 2001. Clinical and histopathological features, therapy and follow-up were evaluated retrospectively and compared with the literature.
RESULTS: All tumours were located in the first and second portions of the duodenum. Three of six aNTs presented with jaundice, and four of six naNTs were incidental findings. Two patients with naNTs showed Zollinger-Ellison syndrome and two with aNTs VRD. Of the six patients with naNTs, four were treated by local excision (two endoscopically, two surgical resection), one by Kausch-Whipple operation and in one patient the tumour was an incidental finding in the Billroth II specimen. Four of the six patients with aNTs underwent Kausch-Whipple procedure, one patient ampullectomy (gangliocytic paraganglioma) and one patient palliative chemotherapy. The size of the naNTs were less than 0.6 cm, whereas the size of the aNTs ranged from 1.5 cm to 4 cm. Tumour size of aNTs had no correlation with depth of invasion and metastases. Metastases were found in two aNTs and none of the naNTs. Immunohistochemically tumour cells expressed somatostatin in 5 of 6 aNTs and gastrin in 1 of 6 aNTs and in two gastrinomas. There was no hospital mortality. Two patients died for reasons not related to the tumour. Tumour excision of both patients with gastrinomas was not curative. Three patients with naNTs and four with aNTs are alive without disease. One patient with palliative treatment of a metastasising aNT is alive 66 months after diagnosis.
CONCLUSION: Non-ampullary duodenal NTs differ clinically, histologically and immunohistochemically as well as with respect to the extent of resection from NTs of the ampulla of Vater.

Entities:  

Mesh:

Year:  2001        PMID: 11819111     DOI: 10.1007/s00423-001-0260-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  11 in total

Review 1.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

3.  Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  R García-Carbonero; F Vilardell; P Jiménez-Fonseca; R González-Campora; E González; M Cuatrecasas; J Capdevila; I Aranda; J Barriuso; X Matías-Guiu
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

Review 4.  Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.

Authors:  Toshimitsu Iwasaki; Satoshi Nara; Yoji Kishi; Minoru Esaki; Kazuaki Shimada; Nobuyoshi Hiraoka
Journal:  Langenbecks Arch Surg       Date:  2016-12-03       Impact factor: 3.445

5.  HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma.

Authors:  Zhengping Zhuang; Chunzhang Yang; Ales Ryska; Yuan Ji; Yingyong Hou; Sky D Graybill; Petra Bullova; Irina A Lubensky; Günter Klöppel; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2016-04-29       Impact factor: 5.678

Review 6.  Evaluation and management of periampullary tumors.

Authors:  William A Ross; Mike M Bismar
Journal:  Curr Gastroenterol Rep       Date:  2004-10

Review 7.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

8.  Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.

Authors:  M Johannes Rosentraeger; Nele Garbrecht; Martin Anlauf; Andreas Raffel; Wolfram T Knoefel; Bertram Wiedenmann; Günter Klöppel
Journal:  Virchows Arch       Date:  2015-12-09       Impact factor: 4.064

9.  Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.

Authors:  Bobby V M Dasari; Sarah Al-Shakhshir; Timothy M Pawlik; Tahir Shah; Ravi Marudanayagam; Robert P Sutcliffe; Darius F Mirza; Paolo Muiesan; Keith J Roberts; John Isaac
Journal:  J Gastrointest Surg       Date:  2018-06-04       Impact factor: 3.452

10.  Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery.

Authors:  Mathias Fasshauer; Thomas Lincke; Helmut Witzigmann; Regine Kluge; Andrea Tannapfel; Michael Moche; Michael Buchfelder; Stephan Petersenn; Juergen Kratzsch; Ralf Paschke; Christian A Koch
Journal:  BMC Cancer       Date:  2006-04-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.